AVCTF
Price
$0.64
Change
+$0.11 (+20.75%)
Updated
Jul 25 closing price
Capitalization
220.95M
PHMMF
Price
$92.57
Change
-$1.24 (-1.32%)
Updated
Jun 23 closing price
Capitalization
1.68B
Interact to see
Advertisement

AVCTF vs PHMMF

Header iconAVCTF vs PHMMF Comparison
Open Charts AVCTF vs PHMMFBanner chart's image
Avacta Group
Price$0.64
Change+$0.11 (+20.75%)
Volume$4.8K
Capitalization220.95M
Pharma Mar SA
Price$92.57
Change-$1.24 (-1.32%)
Volume$2.69K
Capitalization1.68B
AVCTF vs PHMMF Comparison Chart in %
Loading...
AVCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHMMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVCTF vs. PHMMF commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVCTF is a Buy and PHMMF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (AVCTF: $0.64 vs. PHMMF: $92.57)
Brand notoriety: AVCTF and PHMMF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVCTF: 365% vs. PHMMF: 53%
Market capitalization -- AVCTF: $220.95M vs. PHMMF: $1.68B
AVCTF [@Biotechnology] is valued at $220.95M. PHMMF’s [@Biotechnology] market capitalization is $1.68B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVCTF’s FA Score shows that 0 FA rating(s) are green whilePHMMF’s FA Score has 1 green FA rating(s).

  • AVCTF’s FA Score: 0 green, 5 red.
  • PHMMF’s FA Score: 1 green, 4 red.
According to our system of comparison, PHMMF is a better buy in the long-term than AVCTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVCTF’s TA Score shows that 2 TA indicator(s) are bullish while PHMMF’s TA Score has 5 bullish TA indicator(s).

  • AVCTF’s TA Score: 2 bullish, 4 bearish.
  • PHMMF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PHMMF is a better buy in the short-term than AVCTF.

Price Growth

AVCTF (@Biotechnology) experienced а +41.60% price change this week, while PHMMF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

PHMMF is expected to report earnings on Apr 24, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHMMF($1.68B) has a higher market cap than AVCTF($221M). PHMMF YTD gains are higher at: 14.185 vs. AVCTF (12.779).
AVCTFPHMMFAVCTF / PHMMF
Capitalization221M1.68B13%
EBITDAN/A22.9M-
Gain YTD12.77914.18590%
P/E RatioN/A69.56-
RevenueN/A176M-
Total CashN/A141M-
Total DebtN/A51.9M-
FUNDAMENTALS RATINGS
PHMMF: Fundamental Ratings
PHMMF
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
68
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVCTFPHMMF
RSI
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 3 days ago
52%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
46%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
41%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
32%
Bullish Trend 2 days ago
45%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
32%
Bullish Trend 2 days ago
46%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 4 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
AVCTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHMMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSRAX8.67N/A
N/A
Fidelity Advisor Strategic Real Ret A
VVOAX22.37N/A
N/A
Invesco Value Opportunities A
PGTDX65.08N/A
N/A
Putnam Global Technology C
TEOOX9.88N/A
N/A
Transamerica Emerging Markets Eq R6
LVPIX111.23N/A
N/A
ProFunds Large Cap Value Inv

AVCTF and

Correlation & Price change

A.I.dvisor tells us that AVCTF and KZIA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AVCTF and KZIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVCTF
1D Price
Change %
AVCTF100%
+20.54%
KZIA - AVCTF
26%
Poorly correlated
-1.41%
PHMMF - AVCTF
20%
Poorly correlated
N/A
BETRF - AVCTF
15%
Poorly correlated
+9.46%
AURX - AVCTF
11%
Poorly correlated
N/A
BPMUF - AVCTF
9%
Poorly correlated
N/A
More

PHMMF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHMMF has been loosely correlated with DRUG. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PHMMF jumps, then DRUG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHMMF
1D Price
Change %
PHMMF100%
N/A
DRUG - PHMMF
42%
Loosely correlated
+10.83%
CSCI - PHMMF
22%
Poorly correlated
-1.52%
KALV - PHMMF
21%
Poorly correlated
-6.54%
ACAD - PHMMF
21%
Poorly correlated
+0.87%
AVCTF - PHMMF
20%
Poorly correlated
+20.54%
More